ArticleCureus2026

Survival and Quality of Life After Reirradiation With Concurrent Pemetrexed/Erlotinib Followed by Maintenance Erlotinib for Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma: Final Report of a Phase I/II Trial.

Ryan T Hughes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.